Content area
Full text
A human antitoxin for babies with botulism allows them to leave the hospital weeks earlier than those who aren't treated and trims millions from their medical bills, researchers report.
The study, in the recent New England Journal of Medicine, marks the crowning achievement of an unprecedented research and development effort, not by a major drug firm but by experts at California's Department of Health Services and volunteers willing to donate their blood for the babies' sake.
"The treatment of just a few hundred patients has averted more than 20...